Mostrando resultados 19 a 38 de 47
< Anterior
Siguiente >
| Vista previa | Fecha de publicación | Título | Autor(es) |
 | 2021 | Fluoxetine for the symptomatic treatment of Multiple System Atrophy : the MSA-FLUO trial | Rascol, Olivier ; Cochen De Cock, Valérie ; Pavy-Le Traon, Anne ; Foubert Samier, Alexandra ; Thalamas, Claire ; Sommet, Agnès ; Rousseau, Vanessa ; Pérez Lloret, Santiago ; Fabbri, Margherita ; Azulay, Jean Philippe ; Corvol, Jean-Christophe ; Couratier, Philippe ; Damier, Philippe ; Defebvre, Luc ; Durif, Franck ; Geny, Christian ; Houeto, Jean-Luc ; Remy, Philippe ; Tranchant, Christine ; Verin, Marc ; Tison, François ; Meissner, Wassilios G. |
 | 2019 | Genetic factors influencing the development and treatment of cognitive impairment and psychosis in Parkinson’s disease | Pérez Lloret, Santiago ; Bernath, Viviana ; Barrantes, Francisco José |
 | 2023 | Genetics of neurogenic orthostatic hypotension in Parkinson’s disease, results from a cross-sectional in silico study | Chevalier, Guenson ; Udovin, Lucas D. ; Otero Losada, Matilde ; Bordet, Sofía ; Capani, Francisco ; Luo, Sheng ; Goetz, Christopher ; Pérez Lloret, Santiago |
 | 2010 | Heart rate nonlinear dynamics during sudden hypoxia at 8,230 m simulated altitude | Vigo, Daniel Eduardo ; Pérez Lloret, Santiago ; Videla, Alejandro J. ; Pérez Chada, Daniel ; Hünicken, Horacio M. ; Mercuri, Jorge ; Romero, Ramón ; Nicola Siri, Leonardo C. ; Cardinali, Daniel Pedro |
 | 2021 | How much time is needed in clinical practice to reach a diagnosis of clinically established Parkinson’s disease? | Rossi, Malco Damián ; Pérez Lloret, Santiago ; Merello, Marcelo |
 | 2015 | Management of constipation in Parkinson’s disease | Rossi, Marcelo ; Merello, Marcelo ; Pérez Lloret, Santiago |
 | 2021 | Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s disease | Pérez Lloret, Santiago ; Cardinali, Daniel Pedro |
 | 2023 | Myocarditis and pericarditis post-mRNA covid-19 vaccination: insights from a pharmacovigilance perspective | Alami, Abdallah ; Villeneuve, Paul J. ; Farrell, Patrick J. ; Mattison, Donald ; Farhat, Nawal ; Haddad, Nisrine ; Wilson, Kumanan ; Gravel, Christopher A. ; Crispo, James A. G. ; Pérez Lloret, Santiago ; Krewski, Daniel |
 | 2023 | Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome: a translational perspective | Bordet, Sofía ; Luaces, Juan Pablo ; Herrera, María Inés ; Gonzalez, Liliana Mirta ; Kobiec, Tamara ; Pérez Lloret, Santiago ; Otero Losada, Matilde ; Capani, Francisco |
 | 2020 | Neuroprotective properties of cannabinoids in cellular and animal models : hypotheses and facts | Udovin, Lucas Daniel ; Aguilar, Andrea ; Kobiec, Tamara ; Herrera, María Inés ; Pérez Lloret, Santiago ; Toro-Urrego, Nicolás ; Kölliker Frers, Rodolfo |
 | 2017 | Neuropsychiatric symptoms related to cholinergic deficits in Parkinson’s disease | Pérez Lloret, Santiago ; Peralta, María Cecilia ; Barrantes, Francisco José |
 | 2016 | New insights into orthostatic hypotension in multiple system atrophy : a European multicentre cohort study | Pavy-Le Traon, A. ; Piedvache, A. ; Pérez Lloret, Santiago ; Calandra-Buonaura, G. ; Cochen De Cock, Valérie ; Colosimo, C. ; Cortelli, P. ; Debs, R. ; Duerr, S. ; Fanciulli, A. ; Foubert Samier, Alexandra ; Gerdelat, A. ; Gurevich, T. ; Krismer, F. ; Poewe, W. ; Tison, F. ; Tranchant, C. ; Wenning, G. ; Rascol, O. ; Meissner, W. G. |
 | 2011 | Non-motor symptoms groups in Parkinson's disease patients : results of a pilot, exploratory study | Pérez Lloret, Santiago ; Rossi, Malco Damián ; Merello, Marcelo ; Rascol, Olivier ; Cardinali, Daniel Pedro |
 | 2022 | On the diagnosis of pain in Parkinson disease : a mechanism-based approach | Mylius, Veit ; Pérez Lloret, Santiago ; Ciampi de Andrade, Daniel |
 | 2013 | Orthostatic hypotension in Parkinson's disease | Pérez Lloret, Santiago ; Rey, Verónica ; Pavy-Le Traon, Anne ; Rascol, Olivier |
 | 2020 | Parkinson’s disease in the era of a novel respiratory virus pandemic | Otero Losada, Matilde ; Kobiec, Tamara ; Udovin, Lucas Daniel ; Chevalier, Guenson ; Quarracino, Cecilia ; Menéndez Maissonave, Camila Belén ; Bordet, Sofía ; Capani, Francisco ; Pérez Lloret, Santiago |
 | 2016 | Pharmacotherapies for parkinson's disease symptoms related to cholinergic degeneration | Pérez Lloret, Santiago ; Peralta, María Cecilia ; Barrantes, Francisco José |
 | 2012 | Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an eight-week treatment course | Pérez Lloret, Santiago ; Meza Rojas, Gloria ; Menoni, María Celia ; Ruiz, Gabriela ; Velásquez, Carolina ; Rodriguez, Hernán ; Rey, Verónica ; Cardinali, Daniel Pedro |
 | 2021 | RBD-specific polyclonal F(ab )2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial | Lopardo, Gustavo ; Belloso, Waldo H. ; Nannini, Esteban ; Colonna, Mariana ; Sanguineti, Santiago ; Zylberman, Vanesa ; Munoz, Luciana ; Dobarro, Martín ; Lebersztein, Gabriel ; Farina, Javier ; Vidiella, Gabriela ; Bertetti, Anselmo ; Crudo, Favio ; Alzogaray, Maria Fernanda ; Barcelona, Laura ; Teijeiro, Ricardo ; Lambert, Sandra ; Scublinsky, Darío ; Iacono, Marisa ; Stanek, Vanina ; Solari, Ruben ; Cruz, Pablo ; Casas, Marcelo Martín ; Abusamra, Lorena ; Luciardi, Hector Lucas ; Cremona, Alberto ; Caruso, Diego ; Miguel, Bernardo de ; Millan, Susana ; Kilstein, Yael ; Pereiro, Ana ; Sued, Omar ; Cahn, Pedro ; Spatz, Linus ; Goldbaum, Fernando ; Pérez Lloret, Santiago |
 | 2022 | Risk of myocarditis and pericarditis among young adults following mRNA COVID-19 vaccinations | Alami, Abdallah ; Krewski, Daniel ; Mattison, Donald ; Wilson, Kumanan ; Gravel, Christopher A. ; Villeneuve, Paul J. ; Farrell, Patrick J. ; Pérez Lloret, Santiago |
